ALOX15 and cancer: Cisplatin and paclitaxel enhance miR-522 secretion from CAFs by activating the USP7/hnRNPA1 axis, thereby suppressing ALOX15 and decreasing lipid-ROS accumulation, ultimately leading to decreased chemo-sensitivity in cancer cells [164].